Resources

Cognitive decline in older adults with T2 may start to develop years before diagnosis, even in the prediabetes stages

Study also finds reduced heart rate variability (HRV) in overweight patients with newly diagnosed type 2 diabetes (T2D) and stable coronary artery disease (CAD).

Women who are diagnosed with PCOS are at increased risk for prediabetes.

What do you recommend to your patients as the first choice to treat hypoglycemia? 1. Glucose tablets 2. Glucose gel or liquid 3. Juice, soda or milk 4. Honey or cake gel 5. Hard Candy (Smarties) 6. Other Follow the link to share your opinion and see what your colleagues think!

This class of drugs is typically reserved for individuals with type 1 diabetes or others receiving intensive insulin therapy. It inhibits glucagon secretion and slows gastric emptying: 1. Amylin mimetics 2. GLP-1 receptor agonists 3. DPP-4 inhibitors 4. SGLT-2 inhibitors Did you get it right? Follow the link to find out!

Dr. Richard Bernstein and Diabetes in Control Publisher Steve Freed discuss the results of the Remission of Prediabetes to Normal Glucose Tolerance in Obese Adults with High Protein versus High Carbohydrate Diet: A Randomized Controlled Trial. Dr. Richard Bernstein, MD, FACE, FACN, FACCWS is Director Emeritus of the Peripheral Vascular …

I work in obesity medicine. As many of us know, losing weight isn't the problem for most, but weight regain is. As the saying goes for many, you can't be rich enough or thin enough. Many of our patients come in with unrealistic goals regarding their weight loss, and don't give themselves enough credit for the weight they have lost. Many, for many reasons, regain.

Dr. Jeffrey Mechanick talks with Diabetes in Control Publisher Steve Freed at the 2016 AACE Meeting. In part 2 of this Exclusive Interview, Dr. Mechanick emphasizes the importance of the doctor/patient discussion about proper nutrition and lifestyle and what is required for an effective discussion.

In this week's Homerun Slides, Dr. Stanley Schwartz presents the question of whether the use of continuous glucose monitoring has a place in the current hospital setting.

Control of glucagon release: There is considerable evidence that the control of glucagon secretion is multifactorial and involves direct effects of nutrients on alpha-cell stimulus-secretion coupling as well as paracrine regulation by insulin, somatostatin and, possibly, other mediators such as zinc, γ-amino-butyric acid (GABA) or glutamate. Glucagon secretion is also regulated by circulating hormones and the autonomic nervous system.